Tapentadol is partially metabolized by the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with prescription drugs that increase or repress the activity/expression of one or more of such enzymes, together with with substrates of these enzymes (as a consequence of Competitors for that enzyme); some enzyme mediators/substr… Read More